Diabetic retinopathy (DR) is a leading cause of vision loss in the United States.
1 Prevention of vision loss related to DR depends on identifying qualitative features from clinical examination, fundus photographs, or fluorescein angiography. Optical coherence tomography angiography (OCTA), a noninvasive modality capable of capillary resolution imaging of retinal vasculature,
2 is better suited for quantifying vascular changes related to diabetic retinopathy than conventional imaging and has opened the possibility of a quantitative biomarker to characterize DR.
3